Forgot your password?

typodupeerror
Medicine Open Source Patents News

Glaxo Open Sources Malaria Drug Search Data 80

Posted by samzenpus
from the free-as-a-mosquito dept.
smellsofbikes writes "GlaxoSmithKline, the world's second-largest pharmaceutical company, is putting thousands of possible malaria-treating drugs into the public domain in a move that the Wall Street Journal calls a 'Linux approach' to pharmaceutical screening. Andrew Witty, who is described as the boss of GSK, says the company thinks it is 'imperative to earn the trust of society, not just by meeting expectations but by exceeding them.' Of course, synthesis or discovery of new chemicals is cheap compared to efficacy and qualification studies, but this is a refreshing change from not handing out any information until after everything is patented."
This discussion has been archived. No new comments can be posted.

Glaxo Open Sources Malaria Drug Search Data

Comments Filter:
  • by Anonymous Coward on Wednesday May 26 2010, @10:09PM (#32356936)

    It's Kline, not Klein.

  • by ChefJoe (808832) on Wednesday May 26 2010, @11:58PM (#32357736)
    http://www.nature.com/nature/journal/v465/n7296/full/nature09107.html [nature.com] The paper was already published last week in Nature. There was another paper by Guiguemde and Kip Guy in the same issue that my lab helped with. The problem is that antimalarial drugs need to be affordable for millions of people to take daily in places where people live off less than $1/day. Things like Coartem and even artemisinin combination pills cost too much for most of the countries that need them, due to patents and safe manufacturing facilities or even just raw materials. Luckily, malaria is getting special recognition and that helps a lot with widely dispensing every tool available to combat the parasite.
  • by grcumb (781340) on Thursday May 27 2010, @12:19AM (#32357860) Homepage Journal

    (perhaps they just don't think they'll ever profit from malaria drugs, etc)

    And there you have it. Most of the countries where Malaria is prevalent are not rich countries. However, most people have heard the word Malaria and, even if they don't know what it is or how you get it, this announcement sounds impressive to them. Dengue Fever is also common in many of the areas of the world where Malaria is but they aren't releasing that research. Why? Because no one has heard of it so it's not an effective PR stunt.

    The other reason for not releasing research on Dengue is that there is currently no treatment available whatsoever (unless you count liquids and Panadol to reduce the fever).

    Being the first company to provide a viable treatment is a very attractive prospect. I know this because I just got over a bout of Dengue a couple of months ago, and I would have paid really good money for a treatment. In fact, when I was waiting for my blood test results, I quietly prayed that I had malaria, because although it's a bitch, with treatment it's over quickly. Dengue just has to run its course.

    So yes: No profit from malaria? Open source it. Big profit from Dengue? Keep your cards to your chest.

I'm rated PG-34!!

Working...